Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Construction in Progress (2019 - 2022)

Historic Construction in Progress for Eton Pharmaceuticals (ETON) over the last 3 years, with Q4 2022 value amounting to $12000.0.

  • Eton Pharmaceuticals' Construction in Progress changed N/A to $12000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $12000.0, marking a year-over-year change of. This contributed to the annual value of $12000.0 for FY2022, which is N/A changed from last year.
  • Per Eton Pharmaceuticals' latest filing, its Construction in Progress stood at $12000.0 for Q4 2022.
  • Eton Pharmaceuticals' Construction in Progress' 5-year high stood at $873000.0 during Q1 2019, with a 5-year trough of $1000.0 in Q3 2020.
  • In the last 3 years, Eton Pharmaceuticals' Construction in Progress had a median value of $9000.0 in 2019 and averaged $130571.4.
  • The largest annual percentage gain for Eton Pharmaceuticals' Construction in Progress in the last 5 years was 6666.67% (2020), contrasted with its biggest fall of 9954.18% (2020).
  • Over the past 3 years, Eton Pharmaceuticals' Construction in Progress (Quarter) stood at $9000.0 in 2019, then tumbled by 88.89% to $1000.0 in 2020, then soared by 1100.0% to $12000.0 in 2022.
  • Its Construction in Progress was $12000.0 in Q4 2022, compared to $12000.0 in Q1 2022 and $1000.0 in Q3 2020.